References
- Byl F. Sudden hearing loss: eight years experience and suggested prognostic table. Laryngoscope 1984; 94: 647–60.
- Nakashima T, Yanagita N, Ohno Y, Kanzaki J, Shitara T. Comparative study on sudden deafness by two nationwide epidemiological surveys in Japan. Acta Oto-laryngol (Stockholm) 1994; 514: 14–6.
- Mattox D, Lyles A. Idiopathic sudden sensorineural hearing loss. Am J Otol 1989; 10: 242–7.
- Einer H, Tengborn L, Axelsson A, Edström S. Sudden sensorineural hearing loss and hemostatic mechanisms. Arch Otolaryngol Head Neck Surg 1994; 120: 536–40.
- Lalanne MC, Doutremepuich C, Boj F, Traissac L. Some hemostatic and hemorheological disorders in auditory and vestibular impairments. Thrombosis Research 1992; 66: 787–91.
- Shiraishi T, Kubo T, Okumura S. Hearing recovery in sudden deafness patients using a modified defibrinogena-tion therapy. Acta Otolaryngol (Stockh) 1993; Suppl 501: 46–50.
- Friederich G, Pilger E. Lipoproteins in cochleovestibular disorders. Arch Otolaryngol 1981; 232: 101–5.
- Hesse G, Hesch R. Evaluation of risk factors for different forms of inner ear hearing disorders. HNO 1986; 34: 503–7.
- Seplowitz A, Chien S, Smith F. Effects of lipoproteins on plasma viscosity. Atherosclerosis 1981; 38: 89–95.
- Dintenfass L, Kammer S. Plasma viscosity in 615 sub-jects. Effect of fibrinogen, globulin, and cholesterol in normals, peripheral vascular disease, retinopathy and melanoma. Biorheology 1977; 14: 247–51.
- Kanakaraj O, Singh M. Influence of hypercholesterolemia on morphological and rheological characteris-tics of erythrocytes. Atherosclerosis 1989; 76: 209–18.
- Seiler C, Hess OM, Buechi M, Suter TM, Krayenbuehl HP. Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries. Circulation 1993; 88: 2139–48.
- Zeiher A, Drexler H, Saurbier B, Just H. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. J Clin Invest 1993; 92: 652–62.
- Ohinata Y, Makimoto K, Kawakami M, Haginomori S, Araki M, Takahashi H. Blood viscosity and plasma viscosity in patients with sudden deafness. Acta Otolar-yngol (Stockh) 1994; 114: 601–7.
- Schuff-Werner P, Schatz E, Seyde W, et al. Improved haemorheology associated with a reduction in plasma fibrinogen and LDL in patients being treated by heparin-induced extracorporeal LDL precipitation (H.E.L.P.). Euro J Clin Invest 1989; 19: 30–7.
- Halevy D, Thiery J, Nagel D, et al. Increased oxidation of LDL in patients with coronary artery disease is independent from dietary vitamins E and C. Arterioscler Thromb 1997; 17: 1432–7.
- Wilhelm H-J, Jung F, Kiesewetter H, Recktenwald C. On haemodilution therapy for patients with sudden loss of hearing: clinical and rheological results. Klinische Wochenschrift 1986; 64: 1058–61.
- Hultcrantz E, Stenquist M, Lyttkens L. Sudden deafness: a retrospective evaluation of dextran therapy. J Otorhi-nolaryngol Relat Spec 1994; 56: 137–42.
- Schüssler G, Geishauser E, Riiger U. Psychosomatische Faktoren beim idiopathischen Hörsturz. HNO 1992; 40: 4–9.
- Suckfüll M, Thiery J, Wimmer CH, Mees K. Hyperc-holesterolemia and hyperfibrinogenemia in sudden hear-ing loss. Laryngorhinootologie 1997; 76: 453–7.
- Ciuffetti G, Scardazza A, Serafini G, Lombardini R, Mannarino E, Simoncelli C. Whole-blood filterability in sudden deafness. Laryngoscope 1991; 101: 65–7.
- Gold S, Kamerer D, Hirsch B, Cass S. Hypercoagulability in otologic patients. Am J Otolaryngol 1993; 14: 327–31.
- Anonymous. Lipoprotein (a) selectively impairs receptor-mediated endothelial vasodilator function of the human coronary circulation. J Am Coll Cardiol 1997; 30: 927–34.
- Ren T, Nuttall A, Miller J. ATP-induced cochlear blood flow changes involve the nitric oxide pathway. Hear Res 1997; 112: 87–94.
- Brechtelsbauer P, Nuttall A, Miller J. Basal nitric oxide production in regulation of cochlear blood flow. Hear Res 1994; 77: 38–42.
- Anonymous The effect of cholesterol-lowering and an-tioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 1995; 332: 488–93.
- Mellwig K, Baller D, Gleichmann U, et al. Improvement of coronary vasodilatation capacity through single LDL apheresis. Atherosclerosis 1998; 139: 173–8.